<DOC>
	<DOCNO>NCT01581073</DOCNO>
	<brief_summary>The purpose study ask whether treat non-diabetic chronic kidney disease ( CKD ) patient GFR 8-20mL/min/1.73m2 darbepoetin Alfa target Hb 11.0 13.0g/dL preserve renal function well target Hb 9.0 and11.0g/dL . The investigator also ask whether high Hb target 11 13g/dL cause high adverse event regard cardiovascular disease compare low Hb target 9 11g/dL .</brief_summary>
	<brief_title>PRevention End Stage Kidney Disease Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease</brief_title>
	<detailed_description>Anemia common among patient chronic kidney disease ( CKD ) associate increase risk cardiovascular renal event . Although erythropoiesis stimulate agent ( ESA ) use correct anemia , use ESA ( hemoglobin level approximately 13 g/dL ) reduce cardiovascular renal event diabetic CKD patient . Subgroup analysis recent randomize study suggest use darbepoetin alfa target Hb 11 13 g/dL may preserve renal function well target Hb 9 11g/dL non-diabetic CKD patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>1 . CKD patient receive chronic dialysis 2. eGFR 8 less 20 mL/min/1.73m2 determine twice last 12 week . 3 . CKD patient renal anemia Hb le 10g/dL within last 8 week 4 . CKD patient TSAT 20 % high serum ferritin 100ng/mL high . 5 . CKD patient treat standard care 6 . CKD patient provide write informed consent . 1 . Diabetes ( treat , HbA1c 6.4 % IFCC ) 2 . CKD patient treat ESA epoetins darbepoetin . 3 . CKD patient treat epoetin 24000 IU/4w . 4 . CKD patient treat darbepoetin 90Î¼g/4w . 5 . Uncontrolled hypertension ( 180/10mmHg high ) 6 . Heart failure ( NYHA III IV ) 7. malignancy , hematological disorder 8. malnutrition 9 . Active continuous gastrointestinal tract bleed 10 . ANCA associate glomerulonephritis , acute infection , active SLE 11 . CKD patient undergo dialysis receive transplantation within 6 month 12 . Myocardial infarction within last 6 month 13 . Stroke pulmonary embolism within last 12 month 14 . Severe allergy 15 . Pregnant woman , woman lactation , CKD patient plant get pregnant 16 . Allergy erythropoetin 17 . Ineligible patient accord investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>renal anemia</keyword>
	<keyword>erythropoiesis stimulating agent</keyword>
	<keyword>hemoglobin</keyword>
	<keyword>non-diabetes</keyword>
	<keyword>CKD</keyword>
	<keyword>Chronic Kidney Disease patient without diabetes</keyword>
</DOC>